Data as of November 13, 2026

Kurvelo-28 Tablet

LEVONORGESTREL AND ETHINYL ESTRADIOL

Brand: Kurvelo

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$7.03/ fill$0.12 / EA
FUL
$6.57/ fill$0.11 / EA
AMP
$2.68/ fill$0.05 / EA
Medicaid FFS
$16.91/ fill
Medicaid MCO
$14.12/ fill

Sources: cms/nadac:price-ladder · cms/ful:generic-ceiling · cms/sdud

What's in the reimbursement

Ingredient cost (57.8 units/fill)$7.03
Dispensing fee & other (state-fixed, not margin)$9.88
Total reimbursed per fill$16.91

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 29 fee-for-service states, 34 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-10-28; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology